Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
rp169666-10μg
|
10μg |
≥10
|
$139.90
|
|
|
rp169666-50μg
|
50μg |
10
|
$299.90
|
|
|
rp169666-100μg
|
100μg |
10
|
$399.90
|
|
|
rp169666-1mg
|
1mg |
1
|
$2,999.90
|
|
Animal Free, ≥95% (SDS-PAGE), Active, 293F cell, C-His tag, 1-239 aa
| Product Name | Recombinant Human PD-L1 Protein |
|---|---|
| Synonyms | B7 H | B7 H1 | B7 homolog 1 | B7-H1 | B7H | B7H1 | CD 274 | CD-274 | CD274 | CD274 antigen | CD274 molecule | MGC142294 | MGC142296 | OTTHUMP00000021029 | PD L1 | PD-L1 | PD1L1_HUMAN | PDCD1 ligand 1 | PDCD1L1 | PDCD1LG1 | PDL 1 | PDL1 | Programmed cell d |
| Grade | Animal Free, Bioactive, Carrier Free |
| Product Description |
Purity: ≥95%, by SDS-PAGE visualized with Coomassie® Blue Staining. |
| Specifications & Purity | Animal Free, Carrier Free, Bioactive, ≥95%(SDS-PAGE) |
| Bioactivity | Immobilized Recombinant Human PD-L1 Protein (rp169666) at 2.0 μg/mL can bind Sugemalimab (anti-PD-L1) (Ab175662) with the EC50 of 169.70 ng/mL. Immobilized Recombinant Human PD-L1 Protein (rp169666) at 1.0 μg/mL can bind Avelumab (anti-PD-L1) (A412006) with the EC50 of 77.96 ng/mL. Immobilized Recombinant Human PD-L1 Protein (rp169666) at 1.0 μg/mL can bind Envafolimab (anti-PD-L1) (Ab170617) with the EC50 of 339.40 ng/mL. Immobilized Recombinant Human PD-L1 Protein (rp169666) at 1.0 μg/mL can bind Durvalumab (anti-PD-L1) (D412005) with the EC50 of 35.40 ng/mL. |
| Endotoxin Concentration | <1.0 EU/μg |
| Expression System | HEK293 |
| Amino Acids | 1-239 aa |
| Sequence | MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHHHHHH |
| Protein Tag | C-His |
| Accession # | Q9NZQ7 |
| Predicted molecular weight | 26.1 kDa |
| SDS-PAGE | 30.7-37.3 kDa, under reducing conditions; 28.6-36.2 kDa, under non-reducing conditions. |
| Shape | Lyophilized |
|---|---|
| Reconstitution | We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute at 1.0 mg/mL in sterile distilled water. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions. |
| Storage Temp | Store at -20°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at -20°C for 1 year. Avoid freeze / thaw cycle. |
Recombinant Human PD-L1 Protein (rp169666) - ELISA
Immobilized Recombinant Human PD-L1 Protein (rp169666) at 2.0 μg/mL can bind Sugemalimab (anti-PD-L1) (Ab175662) with the EC₅₀ of 169.70 ng/mL.
Recombinant Human PD-L1 Protein (rp169666) - ELISA
Immobilized Recombinant Human PD-L1 Protein (rp169666) at 1.0 μg/mL can bind Avelumab (anti-PD-L1) (A412006) with the EC₅₀ of 77.96 ng/mL.
Recombinant Human PD-L1 Protein (rp169666) - ELISA
Immobilized Recombinant Human PD-L1 Protein (rp169666) at 1.0 μg/mL can bind Envafolimab (anti-PD-L1) (Ab170617) with the EC₅₀ of 339.40 ng/mL.
Recombinant Human PD-L1 Protein (rp169666) - ELISA
Immobilized Recombinant Human PD-L1 Protein (rp169666) at 1.0 μg/mL can bind Durvalumab (anti-PD-L1) (D412005) with the EC₅₀ of 35.40 ng/mL.
Recombinant Human PD-L1 Protein (rp169666) - SDS-PAGE
3 μg/lane of Recombinant Human PD-L1 Protein was resolved with SDS-PAGE under reducing (R) and non-reducing (N) conditions and visualized by Coomassie® Blue staining, showing a band at 30.7-37.3 kDa under reducing conditions and 28.6-36.2 kDa under non-reducing conditions.
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Jun 07, 2024 | rp169666 | |
| Certificate of Analysis | Jun 07, 2024 | rp169666 | |
| Certificate of Analysis | Jun 07, 2024 | rp169666 | |
| Certificate of Analysis | Jun 07, 2024 | rp169666 |